Expression of PRKAA1 (AMPK signaling), which held the highest contribution amongst PC3 loadings, was elevated in KIRC, LUSC, and PRAD tumor samples, while only being moderately or lowly expressed in HNSC, THCA, and THYM tumor samples. The gene discussed is PRKAA1; the disease is prostate adenocarcinoma.